Roche secured CE Mark approval for its mass spectrometry reagent pack, expanding its in-vitro diagnostics menu. This makes Roche's offering the broadest available for any automated mass spectrometry platform, with 39 tests now. The tests include therapeutic drug monitoring for antibiotics, immunosuppressants, steroid hormones, and vitamin D metabolites. This automated solution replaces manual processes, improving turnaround times and standardizing care. The comprehensive menu allows clinicians to make quicker and more precise diagnoses. The cobas Mass Spec solution can integrate with Roche’s existing laboratory systems for streamlined workflows. Roche's solution has received "moderate complexity" categorization in the US, broadening its clinical utility. Roche is committed to expanding this menu further in the coming years. The technology provides the sensitivity and specificity of gold-standard testing.